1. Home
  2. CMCO vs CDNA Comparison

CMCO vs CDNA Comparison

Compare CMCO & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus McKinnon Corporation

CMCO

Columbus McKinnon Corporation

HOLD

Current Price

$16.41

Market Cap

555.6M

Sector

Industrials

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$54.05

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCO
CDNA
Founded
1875
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
555.6M
2.6B
IPO Year
2002
2007

Fundamental Metrics

Financial Performance
Metric
CMCO
CDNA
Price
$16.41
$54.05
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$21.00
$28.00
AVG Volume (30 Days)
341.3K
1.0M
Earning Date
05-27-2026
04-28-2026
Dividend Yield
1.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.13
Revenue
$936,240,000.00
$48,324,000.00
Revenue This Year
$19.73
$16.01
Revenue Next Year
$82.91
$11.31
P/E Ratio
N/A
$26.52
Revenue Growth
3.27
18.93
52 Week Low
$11.99
$13.95
52 Week High
$24.40
$56.85

Technical Indicators

Market Signals
Indicator
CMCO
CDNA
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
CMCO
CDNA

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a world-wide designer, manufacturer and marketer of intelligent motion solutions for material handling that move the world forward and improve lives by efficiently and ergonomically moving, lifting, positioning and securing materials. Its key products include hoists, crane components, precision conveyor systems, rigging tools, light rail workstations and digital power and motion control systems. These are relevant, professional-grade solutions that solve its customers critical material handling requirements. The company has one operating and reportable segment. It has presence in United State, Germany, Europe, Middle East, and Africa (Excluding Germany), Canada, Asia Pacific, and Latin America. It has majority of sales from United States.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: